Picture of Biohit Oyj logo

BIOBV Biohit Oyj Cashflow Statement

0.000.00%
fi flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Annual cashflow statement for Biohit Oyj, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
R2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-1.50.6011.852.572.7
Depreciation
Non-Cash Items-0.0130.7190.1990.0850.4
Other Non-Cash Items
Changes in Working Capital-0.9190.047-1.51-2.41-4.3
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities-0.4441.850.9020.586-0.7
Capital Expenditures-0.033-0.059-0.248-0.402-0.6
Purchase of Fixed Assets
Other Investing Cash Flow Items0.793-0.566-0.4620.4821.8
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities0.76-0.625-0.710.081.2
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-0.266-0.186-0.199-0.23-0.3
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.0631.020.0030.4740.2